Measles-containing-vaccine first-dose (MCV1) immunization coverage in Czechia
Czechia: Measles-containing-vaccine first-dose (MCV1) immunization coverage was 84.0% in 2025. ▼ Falling
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Czechia, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for measles-containing-vaccine first-dose (mcv1) immunization coverage in Czechia is 84.0%, measured in 2025. That is the lowest value across all 26 years on record.
The figure is down 5.6% on the previous year and down 15.2% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Czechia peaked at 99.0% in 2013 and was at its lowest, 84.0%, in 2025.
That places Czechia 128th out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently falling across the 26 years of available data.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Czechia, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 97.0% | — |
| 2001 | 97.0% | +0.0% |
| 2002 | 98.0% | +1.0% |
| 2003 | 97.0% | -1.0% |
| 2004 | 97.0% | +0.0% |
| 2005 | 97.0% | +0.0% |
| 2006 | 97.0% | +0.0% |
| 2007 | 98.0% | +1.0% |
| 2008 | 97.0% | -1.0% |
| 2009 | 98.0% | +1.0% |
| 2010 | 98.0% | +0.0% |
| 2011 | 98.0% | +0.0% |
| 2012 | 98.0% | +0.0% |
| 2013 | 99.0% | +1.0% |
| 2014 | 99.0% | +0.0% |
| 2015 | 99.0% | +0.0% |
| 2016 | 98.0% | -1.0% |
| 2017 | 97.0% | -1.0% |
| 2018 | 96.0% | -1.0% |
| 2019 | 92.0% | -4.2% |
| 2020 | 94.0% | +2.2% |
| 2021 | 97.0% | +3.2% |
| 2022 | 97.0% | +0.0% |
| 2023 | 87.0% | -10.3% |
| 2024 | 89.0% | +2.3% |
| 2025 | 84.0% | -5.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 97.3% | 97.0% | 98.0% | 10 |
| 2010s | 97.4% | 92.0% | 99.0% | 10 |
| 2020s | 91.3% | 84.0% | 97.0% | 6 |
Countries ranked near Czechia
More health data for Czechia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.7726 % change on previous year (2090)
- Heat deaths vs projected death rates 1,169 (2090)
- Un projection of annual infant deaths 34 (2100)
- Population ages 0-14, female, annual growth rate -2.28 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.0735 units per person (2025)
- Population ages 0-14, male, annual growth rate -2.1 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.0773 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Czechia?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Czechia was 84.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Czechia?
- The highest recorded value was 99.0% in 2013.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Czechia?
- The lowest recorded value was 84.0% in 2025.
- How does Czechia rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Czechia ranks 128th out of 194 countries with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Czechia?
- Over the last ten years it is down 15.2%. The long-run trend across the full record is falling.
- Where does this Czechia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).